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Background. Vulvovaginal candidiasis is a common infection. The aim of this study was to identify the species of vaginal Candida
isolates by using multiplex PCR technique. Methods. 191 isolates from patients admitted to Mahdieh hospital were identified.
The vaginal swab specimens were cultured on Sabouraud Dextrose Agar. The ITS1 region between the 18S and 5.8S rRNA
genes and a specific DNA fragment within the ITS2 region were amplified. The multiplex PCR products were separated by
electrophoresis in 2% agarose gel, visualized by staining with ethidium bromide, and photographed. Descriptive statistics, Chi-
square test, and Spearman correlation were used to summarize the findings. Results. C. albicans and C. glabrata were the most
common species isolated from the specimens. A mix of C. glabrata and C. albicans was the most common mixed infection isolated
from the samples. The analysis revealed a significant positive association between older age and infection with C. glabrata isolates
(Spearman’s rho = 0.89, P = 0.015). Conclusion. Multiplex PCR is a fast, yet reliable method to identify Candida species. C.
albicans and then C. glabrata are the two most common causes of vulvovaginal candidiasis. The number of mixed fungal infections
is higher among Iranian population compared to international reports.
1. Introduction
Candida species are the second most common cause of
vulvovaginitis worldwide [1]. The prevalence of vulvovaginal
candidiasis (VVC) is increasing due to the extensive uti-
lization of broad-spectrum antibiotics as well as increased
cases of immunocompromised patients [2, 3]. Nearly 75%
of women over 25 years of age, reported to have at least one
episode of physician approved VVC during their lifetime and
5% experienced recurrent type; which is defined by getting
infected for at least 4 times in a one-year period [4]. However,
20–50% of women have Candida species in their vaginal flora
without showing any clinical symptoms [4, 5]. C. albicans
is the most common and clinically relevant species that
accounts for 85–90% of VVC [4]. However, there has been a
significant trend towards the emergence of other species such
as C. glabrata, C. krusei, and C. parapsilosis which ironically
show more resistance to the first line antifungal treatments
[6]. Hence, the diﬀerentiation of diverse species of Can-
dida in the laboratories seems necessary. Traditionally, the
identification and classification of Candida species were
done by time consuming and unreliable methods such as
serotyping [7], colony morphotyping [8], conventional cul-
ture techniques, and morphological and biochemical analysis
[9]. Nonetheless, the improvements in molecular assay
technology for identifying Candida species, such as randomly
amplified polymorphic DNA analysis (RAPD), has overcome
these limitations during the last couple of years. However,
methods such as single and direct PCR or multiplex PCR
have not been used extensively despite being highly sensitive
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and specific with a shorter turn-around time [10–13].
Multiplex PCR is a rapid diagnostic assay which combines
many specific species primers in one PCR tube. Hence,
it could be used to identify more than one species in a
specimen simultaneously [14]. Very little is known regarding
the epidemiology of VVC in Iran. The aim of this study
was to identify diﬀerent species of Candida in an Iranian
patient population by using diﬀerent methods. Multiplex
PCR method was also evaluated as a rapid and reliable
method to identify Candida species by comparing the results
with the traditional methods such as germ tube formation
in serum, chlamydospore production on Corn Meal Agar
(CMA), and carbohydrate absorption.
2. Materials and Methods
Participants of this study were women with signs and symp-
toms of VVC, who were admitted to the gynecology clinic
in Mahdieh Educational Hospital in Tehran, Iran during a
2-year period from March 2006 to 2008. Participants who
experienced the signs of VVC less than four times (including
their latest admission to the clinic) in the previous year
were categorized in nonrecurrent VVC (NRVVC), and those
who experienced the vaginal itch and secretions equal or
more than four times in the previous year were considered
recurrent VVC (RVVC) after being confirmed by finding
three positive cultures of VVC within a year in their
medical records. Specimens were collected from the first 100
consecutive patients with NRVVC and likewise for the first
100 consecutive patients with RVVC. Each patient was tested
only once at her first visit to the clinic during the two-year
period of the study. Out of a total 200 collected specimens,
25 were excluded from the study due to contamination or
having no signs of fungal growth. Hence, the final number
of specimens was 175. To further evaluate the risk factors
for VVC, we also asked our participants to complete a
questionnaire regarding their demographic and behavioral
characteristics. This study was approved by Iran’s National
Research Ethics Committee. All of the patients signed a
written consent form before participating in the study and
patients’ confidentiality was strictly protected. Furthermore,
no complication was seen after taking the vaginal samples.
Vaginal sampling of the participants performed by using
a sterile swab by the principle researcher and was cultured
simultaneously onto sabouraud dextrose agar medium.
Candida species colonies were also identified by germ tube
formation in serum, chlamydospore production on CMA,
and carbohydrate absorption using the API 20 C-AUX kit
(bioM’erieux, Paris, France), results of which have already
been published elsewhere [15]. Colonies were placed in
transport medium at room temperature before being pro-
cessed for PCR analysis.
DNA extraction and purification were performed using
a Genomic DNA Extraction kit (AccuPrep Bioneer Cor-
poration) based on the guidelines. Multiplex PCR was
performed using the PCR premix kit (AccuPower Bioneer
Corporation) with a total reaction volume of a 50 µL consists
of 10 mM Tris-HCl (pH 8.3), 40 mM KCl, 1.5 mM MgCl2,
0.8 mM deoxyribonucleoside triphosphates (0.2 mM each),
4 µM primers (0.16 µM each), and Taq DNA polymerase
(1 U). The primers used in this reaction were synthesized
at TAGC (Berlin, Germany) including universal primers
(ITS1 [5′-TCCGTAGGTGAACCTGCGG-3′] and ITS2 [5′-
GCTGCGTTCTTCATCGATGC-3′]) [12] and C. albicans-
specific primers (CA3 [5′-GGTTTGCTTGAAAGACGG-
TAG-3′] and CA4 [5′-AGTTTGAAGATATACGTGGTAG-
3′]). A conserved portion of the 18S rDNA region, the
adjacent ITS1, and a portion of the 28S rDNA region were
amplified, using the ITS1 and ITS2 primers. A portion of the
ITS2 region of C. albicans was amplified by including CA3
and CA4 in the PCR mixture. PCR amplification process
was carried out with an Eppendorf thermal cycler under
the following conditions: initial denaturation (94◦C, 3 min);
35 cycles of denaturation (94◦C, 1 min), annealing (60◦C,
1 min), and extension (72◦C, 1 min); final extension (72◦C,
5 min). PCR products were analyzed by electrophoresis
through a 2% agarose gel (Roche) containing ethidium
bromide (Sigma), and UV visualization were performed
according to the protocols provided (UVdoc, GAS9000,
England). The length of the bands was measured by
UVIsoft software. Positive controls were included in each
PCR experiment and consisted of one strain of each C.
albicans ATCC14053 (218 or 219, and 110 bp), C. glabrata
CBS2175 (482 or 483 bp), C. parapsilosis CBS2195 (229 bp),
C. tropicalis CBS94 (218 bp), and C. krusei CBS573 (182 bp).
Pyrogen-free water was used as negative control. Two DNA
bands were identified for C. albicans while one DNA band
was corresponded to other Candida species. An assessment
of the diﬀerent species of RVVC and NRVVC was also
made. Descriptive statistics, chi square test, and Spearman’s
correlation were used to analyze the data.
3. Results
The mean age (±SD) of the 175 participants was 32.4 (±8.2)
years. There was no significant diﬀerence between the mean
age of women with RVVC and those with NRVVC (P <
0.9). There was a significant association between the age of
participants and detection rates of C. albicans (P < 0.05).
The results of the analysis indicate that older participants
were less likely to be infected with C. albicans. However, as
depicted in Figure 1, they were most prone to get infected
with C. glabrata.
Figure 2 shows the results of the multiplex PCR method.
Among vaginal samples, 89.7% contained only one
species of Candida and 10.3% contained more than one
species of Candida. The prevalence of diﬀerent species of
Candida was as follow: C. albicans (65.1%), C. glabrata
(13.1%), C. tropicalis (6.2%), C. krusei (4%), C. guillier-
mondii (0.6%), C. parapsilosis (0.6%), mixed infection of C.
glabrata and C. albicans (5.7%), C. parapsilosis and C. albi-
cans (1.1%), C. krusei and C. albicans (0.6%), C. albicansand
C. tropicalis (0.6%), C. glabrata and C. tropicalis (0.6%), C.
krusei and C. tropicalis (0.6%), C. krusei and C. glabrata
(0.6%), and a combination of C. glabrata, C. krusei, and C.
albicans (0.6%). Only one species of Candida was iden-
tified in 90.2% of participants with NRVVC while 9.8%
of them were infected with more than one species. Also,
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89.7% of those with RVVC were infected with one species
compared to 10.8% who were infected with more. There was
no statistically significant diﬀerence between these groups
(P < 0.3). Chi-square test showed no significant diﬀerence
between the prevalence of Candida species among recurrent
and nonrecurrent groups (P < 0.5). A more detailed
comparison of demographical and behavioral characteristics
of the participants has already been published elsewhere
[15]. The results of the multiplex PCR method perfectly
matched the results of the germ tube test and chlamydospore
production on CMA and API 20C-AUX kit.
4. Discussion
C. albicans is still the most common yeast infection world-
wide. Hence, the reliable and rapid identification method of
this species is a fundamental goal of microbiology labora-
tories. The multiplex PCR method is a highly sensitive and
specific technique based on the results of the previous studies
[16]. Despite their demonstrated reliability, molecular meth-
ods have not been routinely used to identify Candida species.
Liguori et al. compared diﬀerent chromogenic and biological
methods to PCR for C. albicans identification. They pointed
out high incubation time, lack of experienced personnel,
lower sensitivity and specificity, and lower discrimination
power as disadvantages of other methods and suggested
using them for screening and preliminary assays, while
introduced the multiplex PCR as a precise and simple
to implement method with no requirement of toxic and
expensive chemical reagents [17]. This cross-sectional study
used a multiplex PCR method previously used by Chang
et al. [12] to identify the Candida species in a sample of
Iranian population. It has been previously shown that 30.7%
of isolated C. glabrata are resistant to common antifungal
therapies compared to 0.6% of C. albicans [6, 18]. Hence,
including methods which can identify the nonalbicans
species is important and useful in choosing the appropriate
treatment. The results of this study showed that C. glabrata is
more common in women at older age while other species are
Figure 2: Multiplex PCR using primers ITS1, ITS2, CA3, and CA4.
Lane 1: 50-bp DNA ladder. Lane 2: negative control. Lanes 3 to 8, 11
to 13 and 15 to 16: eleven clinical isolates. Lane 9: mixed reference
strains C. krusei CBS573, C. albicans ATCC14053, and C. glabrata
CBS2175, Lane 10: reference strain C. tropicalis CBS94, and Lane
14: reference strain C. parapsilosis CBS2195.
more common among the young population. This finding
is in agreement with previous studies [19–22] and could be
due to the development of antifungal resistance, the immune
response, or hormonal changes among women of older age
[19]. However, the result could be due to an unanticipated
bias, and further studies seem essential to solely address this
observation. The results of this study showed that 10.3%
of participants were infected with more than one species of
Candida which is a higher rate compared to the other studies
conducted in China [23], United States [24], and Jordan
[25]. The first and second most common isolated species
in this study were C. albicans and C. glabratawhich was in
agreement with similar studies conducted worldwide [23,
25–31]. The prevalence of other species had the same pattern
in our study as seen in earlier findings [25, 32–37]. Finally, of
interest is using the Genomic DNA Extraction kit (AccuPrep
Bioneer Corporation) as an eﬀective and rapid method
for extracting the DNA in 35 minutes. This eliminated
the use of phenol-chloroform which is a cumbersome and
tedious step of other PCR methods, resulting in significant
improvements in the processing speed (the whole process
could be completed in less than 6 hours). Another advantage
of Multiplex PCR method is its ability to identify more than
one species in a single specimen. Despite its strengths, our
study was subject to some limitations such as low number
of participants due to the lack of budget and personnel and
collecting samples from patients admitted to one hospital
which can aﬀect the results of this study. Therefore, the
results of our study should be used with caution and further
research is recommended.
5. Conclusion
The results of this study showed that C. albicans is the most
common Candida species in VVC among women followed
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by C. glabrata which has a higher prevalence among older
women. A multiplex PCR method was used to identify the
Candida species which seemed to be a reliable, rapid, and cost
eﬀective technique since it only requires PCR components
and a commercial DNA extraction kit.
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